Indian Vaccines Supplier & Wholesale Distributor.
Routine immunisation and adult/travel vaccines, hepatitis, influenza, rabies, MMR and others.
Vaccines exporter and bulk supplier from India.
M Care supplies bulk vaccine lines under validated cold-chain to importers, national immunisation programmes and government tender buyers across 49+ export markets. We are not the manufacturer; we place your order with the WHO-GMP source line that best fits your market and price, and the paperwork travels with the goods.
Source
WHO-GMP-certified Indian manufacturing line, named on every quote.
Minimum order
No blanket MOQ. Set by the source manufacturer's minimum batch-release quantity for the strength and pack ordered.
Pricing
On request. Indicative FOB or CIF quote, formal proforma on confirmation.
Incoterms
EXW, FOB, CIF, CIP or DAP.
Payment
Letter of credit (sight or usance) and telegraphic transfer.
Documentation
WHO-GMP certificate of the source line, product-specific CoPP, batch CoA, method of analysis, Free Sale Certificate, Certificate of Origin, CTD or eCTD dossier. On request.
Shelf-life
Minimum remaining shelf-life agreed per order and confirmed on the proforma.
Response
Availability and CoPP status within two working days; pre-alert documents before dispatch.
Vaccine supply is GAVI's procurement model first and a cold-chain engineering problem second.
GAVI, the Vaccine Alliance, runs the largest pooled-procurement mechanism in immunisation. UNICEF Supply Division procures on GAVI's behalf, with a multi-year award cycle covering pentavalent (DTwP-HepB-Hib), pneumococcal conjugate, rotavirus, measles, MR, OPV, IPV, HPV, yellow fever, meningococcal A, typhoid conjugate and the COVID-era residual lines. Indian WHO-prequalified manufacturers (Serum Institute, Bharat Biotech, Biological E, Panacea, Sanofi-Shantha) hold the largest share of UNICEF awards by dose. Our role on this lane is the supply-side registration support and shipment coordination, not the GAVI tender itself, which is run by the manufacturer directly.
Outside GAVI, national immunisation programme buying through PEPFAR-aligned Africa CDC pooled procurement, Saudi MoH bulk vaccine tenders, and the EU joint procurement (where applicable for influenza, HPV, MMR catch-up) is the second-largest demand window. Each runs with a different temperature-stability dossier requirement: GAVI/UNICEF wants WHO PQ stability data, GCC wants the SFDA / GHC dossier, EU joint procurement wants a CTD Module 3 stability section that meets EMA's reduced-temperature data convention.
Cold-chain is the constraint, not the molecule. We ship vaccines on validated 2–8°C lanes, typically air-freight in vacuum-insulated panel passive shippers for 72-hour lanes (BOM-NBO, BOM-LOS, BOM-LHR), or active CSafe / Envirotainer for 120-hour lanes (BOM-DKR, BOM-ABV-routed). Pre-conditioning at the manufacturing-plant cold room, in-transit IoT logging, on-arrival logger read-out, hold-or-release recommendation issued to the importer's RP, all standard against vaccine consignments. Cold-chain excursion CAPA opens before dispatch, not after.
Indian vaccine supply, validated 2–8°C end-to-end.
India is the world's largest vaccine manufacturer by volume and the backbone of the UN-procured immunisation pipeline, Serum Institute, Bharat Biotech, Biological E and Panacea between them supply more than half the routine-immunisation doses shipped through UNICEF and Gavi each year. As an Indian vaccine supplier and wholesale supplier, M Care ships from WHO-PQ and WHO-GMP origins across 30+ active lines: hepatitis B and combination paediatric series, inactivated influenza (trivalent and quadrivalent), rabies, typhoid, MMR, meningococcal, pneumococcal and travel vaccines. Cold-chain is validated at 2–8°C from the Mumbai consolidator through the airline's pharma-handling SOP to the destination-country EPI warehouse or private importer, with temperature-monitoring devices placed on every pallet and CoA, lot traceability and WHO-PQ certificates in the documentation pack. Destinations include ministry EPI programmes across Africa (NAFDAC Nigeria, PPB Kenya, NDA Uganda, EFDA Ethiopia), GCC public-sector tenders (MOHAP, SFDA), UK named-patient cover and NGO procurement through UNICEF, WHO, Gavi and the Global Fund.
30+ lines across 20 active molecules.
Each molecule below is supplied against hospital, tender, and retail orders, in multiple strengths, dosage forms and pack sizes. Brand names shown are illustrative; substitute brands and generic equivalents are available on request.
| Molecule | Class · indication | Brand examples on our roster |
|---|---|---|
| Hepatitis 4 lines available | Hepatitis B Vaccine Bevac Vaccine 100mcg; Hepatitis B Vaccine 0.5ml Vaccine Revac B; Hepatitis B Vaccine 100IU Heparel Injection | |
| Inactivated 3 lines available | Inactivated influenza vaccine 0.5ml Influvac Tetra Vaccine; Inactivated influenza vaccine FluQuadri Vaccine; Inactivated influenza vaccine (NA) 0.5ml FluQuadri Injection | |
| Diphtheria 2 lines available | Diphtheria Toxoid 0.5ml Vaccine Boostrix; Diphtheria Toxoid Vaccine | |
| Hepatities 2 lines available | Hepatities-B Vaccine 0.5ml Bevac Vaccine; Hepatities-B Vaccine 10ml Bevac Vaccine | |
| Influenza 2 lines available | Influenza vaccine 0.25ml Fluquadri; Influenza vaccine 0.5 ml Fluquadri | |
| Rabies 2 lines available | Rabies Human 2.5IU Vaccine; Rabies vaccine, Human 2.5IU Abhayrab Vaccine | |
| Varicella 2 lines available | Varicella Vaccine 0.5ml Injection Varilix; Varicella Vaccine 0.5ml Injection Varivax | |
| Abhay 1 lines available | Abhay-TOX Vaccine | |
| Anti 1 lines available | Anti Rabies Vaccine Injection ACTIZA | |
| Avaxim 1 lines available | Avaxim 80U Pediatric Vaccine | |
| Bacillus 1 lines available | Bacillus Calmette – Guerin Vaccine Tubervac | |
| Biovac 1 lines available | Biovac V Vaccine | |
| Boostrix 1 lines available | Boostrix Vaccine | |
| Cholera 1 lines available | Cholera 1.5ml Oral Vaccine Shanchol | |
| Corona 1 lines available | Corona Virus 5ml vaccine | |
| Haemophilus 1 lines available | Haemophilus B 10mcg Vaccine | |
| Measles 1 lines available | Measles 20ml Vaccines | |
| Pneumococcal 1 lines available | Pneumococcal Polysaccharide Vaccine 25mg Injection Pneumovax 23 | |
| Salmonella 1 lines available | Salmonella Typhi 25mcg VI Vaccine | |
| Typbar 1 lines available | Typbar Vaccine |
Showing the 20 most-stocked molecules in this category. For the full molecule list, dosage forms, pack sizes, and in-country registration status for your destination market, please send us an enquiry.
The documentation pack you'd expect from a regulated-market supplier.
CoA & MoA
Batch-specific certificate of analysis and method of analysis from the manufacturing QC lab.
Certificate of origin
Chamber-attested where the destination market requires it.
Pack insert
Destination-language, destination-regulator-approved patient information leaflet.
Artwork QC
Labels, cartons and shippers reviewed against your market's labelling regs before despatch.
Cold-chain data
Where applicable: pre-shipment validation, in-transit temperature logs, on-arrival inspection record.
Import licence support
Pro-forma invoices, import-permit documentation, and regulatory liaison at the destination.
Where we ship vaccines lines.
M Care ships vaccines pharmaceuticals from India to 20 import markets across the UK, EU, GCC, MENA, sub-Saharan Africa and ASEAN. One WHO-GMP supplier, one documentation trail, one account manager through clearance.
United Kingdom
MHRA-route supply for wholesalers, hospital groups and named-patient importers.
Germany
BfArM and PEI documentation, EU-GMP aligned, shortage-list response when lines go critical.
UAE
MoHAP and DHA registration support, Jebel Ali re-export, DXB direct.
Saudi Arabia
SFDA dossier preparation, eCTD submissions, Jeddah and Riyadh corridors.
Nigeria
NAFDAC registration, Apapa and Tin Can Island clearance, Lagos direct.
Kenya
PPB registration, Mombasa port, onward to Uganda, Tanzania and Rwanda.
Tell us which molecule. We'll take it from there.
Send us the molecule, strength, dosage form, volume and destination market. You'll have a price, a timeline, and a regulatory status inside one working day, from a named person.
Send enquiry → Back to all categories